Loading data
RGCNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 1.3 m USD | 948.29 k USD | 1.07 m USD | 1.58 m USD | 2.51 m USD |
| Operating profit | -11.72 m USD | -3.77 m USD | -4.74 m USD | -6.27 m USD | -7.62 m USD |
| Profit before tax | -11.7 m USD | -3.58 m USD | -4.36 m USD | -6.06 m USD | -7.59 m USD |
| Net income (reported basis) | -11.7 m USD | -3.58 m USD | -4.3 m USD | -5.87 m USD | -7.45 m USD |
| Net income attributable to common shareholders | — | — | — | -5.96 m USD | -7.45 m USD |
| Basic earnings per share | -2.37 USD/share | -0.72 USD/share | -0.87 USD/share | -1.19 USD/share | -0.58 USD/share |
| Diluted earnings per share | -2.37 USD/share | -0.72 USD/share | -0.87 USD/share | -1.19 USD/share | -0.58 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.